Companies: 10,795·Total market cap: $144.5T
Tourmaline Bio, Inc.

Tourmaline Bio, Inc.

TRMLNASDAQHealthcare
$47.98
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio
52W High$48.27
52W Low$11.56
Overview

Tourmaline Bio, Inc. (TRML) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · TRML · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Tourmaline Bio, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

TRML insider buying and selling by quarter

TRML insider selling · TRML insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
4.0M2.0M0
2025 Q1
2025 Q2
2025 Q3
2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · TRML ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

TRML executive sell shares · TRML board member insider trading · TRML insider trading SEC filing

Showing 25 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Thiara Parvinder

Director

Other

Date

Oct 28

Shares

83,782

Price

$48.00

Value

$4.02M ⚡

View Form 4 on SEC.gov

Srivastava Sapna

Director

Other

Date

Oct 28

Shares

518

Price

$48.00

Value

$25K

View Form 4 on SEC.gov

MCDADE MARK

Director

Other

Date

Oct 28

Shares

448,431

Price

$48.00

Value

$21.52M ⚡

View Form 4 on SEC.gov

KANTOFF AARON

Director

Other

Date

Oct 28

Shares

88,281

Price

$48.00

Value

$4.24M ⚡

View Form 4 on SEC.gov

Castelein Caley

Director

Other

Date

Oct 28

Shares

431,939

Price

$48.00

Value

$20.73M ⚡

View Form 4 on SEC.gov

Johnson Kevin Bruce

Chief Regulatory Officer

Other

Date

Oct 28

Shares

40,538

Price

$48.00

Value

$1.95M ⚡

View Form 4 on SEC.gov

Johnson Kevin Bruce

Chief Regulatory Officer

Other

Date

Oct 28

Shares

11,046

Price

Value

View Form 4 on SEC.gov

Jones Susan Dana

CTO

Other

Date

Oct 28

Shares

19,782

Price

$48.00

Value

$950K

View Form 4 on SEC.gov

Jones Susan Dana

CTO

Other

Date

Oct 28

Shares

3,152

Price

Value

View Form 4 on SEC.gov

MIDDLEKAUFF W BRADFORD

CBO, GC and Secretary

Other

Date

Oct 28

Shares

60,988

Price

$48.00

Value

$2.93M ⚡

View Form 4 on SEC.gov

MIDDLEKAUFF W BRADFORD

CBO, GC and Secretary

Other

Date

Oct 28

Shares

8,213

Price

Value

View Form 4 on SEC.gov

Robinson Ryan F.

CFO

Other

Date

Oct 28

Shares

14,366

Price

$48.00

Value

$690K

View Form 4 on SEC.gov

Kulkarni Sandeep Chidambar

CEO · Director

Other

Date

Oct 28

Shares

724,664

Price

$48.00

Value

$34.78M ⚡

View Form 4 on SEC.gov

Kulkarni Sandeep Chidambar

CEO · Director

Other

Date

Oct 28

Shares

30,387

Price

Value

View Form 4 on SEC.gov

Kulkarni Sandeep Chidambar

CEO · Director

Other

Date

Oct 28

Shares

7,000

Price

$48.00

Value

$336K

View Form 4 on SEC.gov

KANTOFF AARON

Director

Gift

Date

Oct 24

Shares

5,000

Price

Value

View Form 4 on SEC.gov

Robinson Ryan F.

CFO

Option

Date

Oct 22

Shares

14,366

Price

$13.92

Value

$200K

View Form 4 on SEC.gov

Kulkarni Sandeep Chidambar

CEO · Director

Option

Date

Oct 22

Shares

25,316

Price

$7.90

Value

$200K

View Form 4 on SEC.gov

Castelein Caley

Director

Gift

Date

Oct 15

Shares

522

Price

Value

View Form 4 on SEC.gov

Johnson Kevin Bruce

Chief Regulatory Officer

Gift

Date

Oct 15

Shares

6,250

Price

Value

View Form 4 on SEC.gov

KANTOFF AARON

Director

Option

Date

Sep 5

Shares

10,000

Price

$9.46

Value

$95K

View Form 4 on SEC.gov

KANTOFF AARON

Director

Option

Date

Sep 5

Shares

37,890

Price

$0.13

Value

$5K

View Form 4 on SEC.gov

Kulkarni Sandeep Chidambar

CEO · Director

Purchase

Date

Aug 21

Shares

1,779

Price

$14.85

Value

$26K

View Form 4 on SEC.gov

Kulkarni Sandeep Chidambar

CEO · Director

Purchase

Date

Aug 16

Shares

5,221

Price

$13.79

Value

$72K

View Form 4 on SEC.gov

MCDADE MARK

Director

Purchase

Date

Jan 29

Shares

100,000

Price

$32.50

Value

$3.25M ⚡

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About TRML insider trading

TRML insider trades

Tourmaline Bio, Inc. (TRML) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including KANTOFF AARON (Director), Kulkarni Sandeep Chidambar (CEO · Director), Johnson Kevin Bruce (Chief Regulatory Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. TRML insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Tourmaline Bio, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

TRML insider trading · 5 questions

The insiders of Tourmaline Bio, Inc. (TRML) include executives and directors such as KANTOFF AARON (Director), Kulkarni Sandeep Chidambar (CEO · Director), Johnson Kevin Bruce (Chief Regulatory Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

TRML board member insider tradingwho are TRML insidersTRML insider rosterTourmaline Bio, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026